Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen
Scienmag
NOVEMBER 9, 2020
Credit: Insilico Tuesday, November 10, 2020 (9AM Beijing) – Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecule generation, and prediction of clinical trial outcomes, today announced that it entered into a multi-target drug discovery agreement with Janssen Pharmaceutica N.V.
53 
Let's personalize your content